EMGEL Trademark

Trademark Overview


On Friday, September 19, 2025, a trademark application was filed for EMGEL with the United States Patent and Trademark Office. The USPTO has given the EMGEL trademark a serial number of 99402676. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, January 29, 2026. This trademark is owned by PepGenix, LLC. The EMGEL trademark is filed in the Pharmaceutical Products category with the following description:

Regenerative medicine products
emgel

General Information


Serial Number99402676
Word MarkEMGEL
Filing DateFriday, September 19, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, January 29, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesRegenerative medicine products

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 19, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePepGenix, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWinston-Salem, NC 27101

Trademark Events


Event DateEvent Description
Friday, September 19, 2025NEW APPLICATION ENTERED
Friday, September 19, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 19, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, January 28, 2026ASSIGNED TO EXAMINER
Thursday, January 29, 2026NON-FINAL ACTION WRITTEN
Thursday, January 29, 2026NON-FINAL ACTION E-MAILED
Thursday, January 29, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords


emgel products medicine regenerative